Recurrent Acroparaesthesia During Febrile Infections
Lancet 363:1698, Bodamer,O.A.,et al, 2004
Contribution of Susceptibility-Weighted Imaging to Acute Stroke Assessment
Stroke 35:1989-1994, Hermier,M. &Nighoghossian,N., 2004
Basal Ganglia Hyperperfusion in a Patient with Systemic Lupus Erythematosus-Related Parkinsonism
Neurol 63:395-396, Lee,P.H.,et al, 2004
Stalevo for Parkinson's Disease
The Medical Letter 46:39, , 2004
Role of Magnetic Resonance Imaging Within Diagnostic Criteria for Multiple Sclerosis
Ann Neurol 56:273-278, Miller,D.H.,et al, 2004
Effective Cabergoline Treatment in Idiopathic Restless Legs Syndrome
Neurol 63:2272-2279, Stiasny-Kolster,K.,et al, 2004
A Double-blind Placebo-controlled Trial of Botulinum Toxin B for Sialorrhea in Parkinson's Disease
Neurol 62:37-40, Ondo,W.G.,et al, 2004
Clinicopath Conf., Leprosy
NEJM 350:166-176, Case 1-2004, 2004
Predicting Major Neurological Improvement With Intravenous Recombinant Tissue Plasminogen Activator Treatment of Stroke
Stroke 35:147-150, Brown,D.L.,et al, 2004
Morning Glory Sign: A Particular MR Finding in Progressive Supranuclear Palsy
Magn Reson Med Sci 3:125-132, Adachi, M., et al, 2004
Heterozygous Niemann-Pick Disease Type C Presenting with Tremor
Neurol 63:2189-2190, Josephs,K.A.,et al, 2004
Spinal Dural Arteriovenous Fistulas: Clinical Features in 80 Patients
JNNP 74:1438-1440, Jellema,K.,et al, 2003
The Neurosurgical Treatment of Pain
Arch Neurol 60:1537-1540, Giller,C.A., 2003
Identification of New Presenilin Gene Mutations in Early-Onset Familial Alzheimer Disease
Arch Neurol 60:1541-1544,1521, Tedde,A.,et al, 2003
Prolactinoma
NEJM 349:2035-2041, Schlechte,J.A., 2003
Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia
NEJM 349:2023-2033, Colao,A.,et al, 2003
Operational Definitions for the NINDS-AIREN Criteria for Vascular Dementia
Stroke 34:1907-1912, van Straaten,E.C.W.,et al, 2003
Pathological Gambling Associated with Dopamine Agonist Therapy in Parkinson's
Neurol 61:422-423, Driver-Dunckley,E.,et al, 2003
Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease
Arch Neurol 60:1059-1064,1043, Chen,H.,et al, 2003
Aortic Dissection Presenting as Acute Ischemic Stroke
Neurol 61:581-582, Wright,V.,et al, 2003
The Utility of MRI in Suspected MS, Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 61:602-611,596, Frohman,E.M.,et al, 2003
Early Alzheimer's Disease
NEJM 349:1056-1063, Kawas,C.H., 2003
A Double-Blind Controlled Trial of Bilateral Fetal Nigral Transplantation in Parkinson's Disease
Ann Neurol 54:403-414, Olanow,C.W.,et al, 2003
Vascular Syndromes of the Thalamus
Stroke 34:2264-2278, Schumahmann,J.D., 2003
Heart Valvular Disease in Patients with Parkinson's Disease Treated with High-Dose Pergolide
Neurol 61:859-861, VanCamp,G.,et al, 2003
Acute Effects and Recovery Time Following Concussion in Collegiate Football Players
JAMA 290:2556-2563,2604, McCrea,M.,et al, 2003
Awakenings From Persistent Vegetative State: Report of Three Cases With Parkinsonism and Brain Stem Lesions on MRI
JNNP 74:1571-1573, Matsuda,W.,et al, 2003
Spinal Cord MRI in Clinically Isolated Optic Neuritis
JNNP 74:1577-1580, Dalton,C.M.,et al, 2003
Validation of Computed Tomographic Middle Cerebral Artery "Dot" Sign
Stroke 34:2636-2640, Leary,M.C.,et al, 2003
Five-Year Follow-up of Bilateral Stimulatioin of the Subthalamic Nucleus in Advanced Parkinson's Disease
NEJM 349:1925-1934,1888, Krack,P.,et al, 2003
Primary Progressive Aphasia--A Language-Based Dementia
NEJM 349:1535-1542, Mesulam,M.-M., 2003
Stroke
Lancet 362:1211-1224, Warlow,C.,et al, 2003
West Nile Virus Encephalitis Involving the Substantia Nigra
Arch Neurol 60:1448-1452, Bosanko,C.M.,et al, 2003
Orthostatic Hypotension in De Novo Parkinson Disease
Arch Neurol 60:1400-1404, Bonuccelli,U.,et al, 2003
Disappearance of Resting Tremor After "Stereotaxic" Thalamic Stroke
Neurol 61:1014-1015, Probst-Cousin,S.,et al, 2003
Measurement of the Ischemic Penumbra With MRI: It's About Time
Stroke 34:2533-2534, Warach,S., 2003
Reversal of Parkinsonism Following Liver Transplantation
Neurol 60:519, Shulman,L.J.,et al, 2003
Slowing Parkinson's Disease Progression
Neurol 60:381-389, Ahlskog,J.E., 2003
Initial Agonist Treatment of Parkinson Disease
Neurol 60:390-394, Albin,R.L. &Frey,K.A., 2003
CMT with Pyramidal Features
Neurol 60:696-699, Vucic,S.,et al, 2003
Early Major Ischemic Changes on Computed Tomography Should Preclude Use of Tissue Plaminogen Activator
Stroke 34:820-821,822, von Kummer,R., 2003
Early Major Ischemic Changes on Computed Tomography Should Not Preclude Use of Tissue Plasminogen Activator
Stroke 34:821-822,822, Lyden,P.,et al, 2003
[123I]b-CIT SPECT is a Useful Method for Monitoring Dopaminergic Degeneration in Early Stage Parkinson's Disease
JNNP 74:294-298,287, Winogrodzka,A.,et al, 2003
Neuropsychological and Quality of Life Outcomes 12 Months After Unilateral Thalamic Stimulation for Essential Tremor
JNNP 74:305-311, Fields,J.A.,et al, 2003
Development in Pain and Neurologic Complaints After Whiplash
Neurol 60:743-761,733, Kasch,H.,et al, 2003
Ten Most Commonly Asked Questions About the Psychiatric Aspects of Parkinson's Disease
The Neurologist 9:50-56, Reich,S.G. & Marsh,L., 2003
Neuronal Loss Is Greater in the Locus Coeruleus Than Nucleus Basalis and Substantia Nigra in Alzheimer and Parkinson Diseases
Arch Neurol 60:337-341, 320, Zarow,C.,et al, 2003
Ipsilateral Truncal Sensory Deficit in a Patient with Ophthalmic Zoster Sine Herpete
Neurol 60:1049-1050, Yamada,S.,et al, 2003
Clinical Features and Natural Histry of Progressive Supranuclear Palsy, A Clinical Cohort Study
Neurol 60:910-916, Nath,W.,et al, 2003
Diffusion-Weighted Imaging Discriminates Progressive Supranuclear Palsy from PD, But Not From the Parkinson Variant of Multiple System Atrophy
Neurol 60:922-927, Seppi,K.,et al, 2003